FDA Adverse Event Injury Summary report: N

GORE® TAG® THORACIC ENDOPROSTHESIS

MDR report key: 4964596 · Received August 4, 2015

Report

Report Number
2017233-2015-00511
Event Type
Injury
Date Received
August 4, 2015
Date of Event
February 13, 2013
Report Date
August 14, 2015
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P040043
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL MANUFACTURER NARRATIVE - (B)(4).

Additional Manufacturer Narrative · 1

THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. USERS ARE MADE AWARE OF THE RISKS ASSOCIATED WITH TYPE II ENDOLEAKS IN THE IFU AND ARE INSTRUCTED TO CONSIDER THE RISKS AND BENEFITS DISCUSSED IN THE IFU FOR EACH PATIENT BEFORE USING THE DEVICES.

Description of Event or Problem · 1

ON (B)(6) 2011, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF A THORACIC AORTIC ANEURYSM USING TWO GORE® TAG® THORACIC ENDOPROSTHESIS (TGT3115/8111234, TGT3415/8096651). THE PROCEDURE WAS CONCLUDED WITH NO ENDOLEAKS IDENTIFIED. ON (B)(6) 2011, THE PATIENT WAS DISCHARGED OF THE HOSPITAL. ANEURYSM DIAMETER WAS 62 MM. NO ENDOLEAKS WERE REPORTED. ON (B)(6) 2011, AT A FOLLOW-UP STUDY, THE ANEURYSM DIAMETER MEASURED 47 MM. A TYPE II ENDOLEAK WAS FOUND. THE PHYSICIAN DECIDED TO MONITOR THE PATIENT. ON (B)(6) 2012, AT A FOLLOW-UP STUDY, THE ANEURYSM DIAMETER MEASURED 49 MM. THE TYPE II ENDOLEAK REMAINED. THE PHYSICIAN DECIDED TO CONTINUE TO MONITOR THE PATIENT. ON (B)(6) 2013, AT A FOLLOW-UP STUDY, THE ANEURYSM DIAMETER MEASURED 61 MM. THE TYPE II ENDOLEAK REMAINED. THE PHYSICIAN DECIDED TO CONTINUE TO MONITOR THE PATIENT. ON (B)(6) 2014, AT A FOLLOW-UP STUDY, THE ANEURYSM DIAMETER MEASURED 59 MM. THE TYPE II ENDOLEAK REMAINED. THE PHYSICIAN DECIDED TO CONTINUE TO MONITOR THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
506173 GORE® TAG® THORACIC ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES 8111234

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other